ArticleLa Tunisie medicale
The journal "La Tunisie Médicale": Soon in the Q2 Quartile, on the SCImago platform.
Article in La Tunisie medicale. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Let's save the indexing of the journal "La Tunisie Médicale".La Tunisie medicaleArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The SCImago platform had just announced, at the beginning of 2022, the new position of the journal «La Tunisie Médicale» (ISSN: 0041-4131; IeSSN: 2724-7031) in the third quartile (Q3) of journals in the field. Medicine/General Medicine, with an SJR index (2021) of 0.29 and an Impact Score (2 years) of 0.53. As for the Scopus® platform, it reported for the journal «La Tunisie Médicale», a CiteScore 2021 of 0.8 (between 2018-2021: 514 citations and 630 documents) and a position at the 34th percentile. To improve its notoriety indices, the new editorial team of the journal "La Tunisie Médicale" will immediately: 1. Select research manuscripts with a high level of evidence; 2. Invite leaders in scientific biomedical writing to actively participate in its special thematic issues; 3. Mobilize an international team of competent, available and committed reviewers.
Indexed as
Identifiers
36206059PMC9581079What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.